TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change in walking speed of the 10 meter-walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of grade 3 or higher radiation treatment related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: End tidal partial pressure of CO2 (EtCO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence and Severity of Serious Adverse Events (SAEs) Assessed as Related to DTX401
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence, Relationship, Severity and Seriousness of Adverse Events of Special Interest (AESIs) for AAV Therapies
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Pregnancy in Patients Treated with DTX401 or Patient's Partner
Endpoint domain: Adverse events/effects
Primary endpoint: Outcomes of Pregnancy in Patients Treated with DTX401 or Patient's Partner
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence and Severity of SAEs of Infusion-Related Reactions Including Hypersensitivity
Endpoint domain: Adverse events/effects
Primary endpoint: Survivorship of THA using Accolade femoral stem
Endpoint domain: Mortality/survival
Primary endpoint: Change in Restless Leg Syndrome symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 100-days incidence of CMV infection
Endpoint domain: Adverse events/effects
Primary endpoint: Satisfaction and psychological reward
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sensory perceptions of EC vaping experience
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Levels of HPHC and other toxicant exposure from vaping e-liquids
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ACR CRISS composite score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of ILD on CT and MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in RBC/Barrier Ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change from baseline plasma glucose concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Sensitive caregiving
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Sensitivity of mt-sDNA compared to Colonoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of mt-sDNA compared to Colonoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participant acceptance of mt-sDNA as a follow up strategy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Physical Capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: State Hopelessness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Log Transformed High Frequency Heart Rate Variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Log Transformed Root Mean Square of Successive Differences Between Normal Heartbeats
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Canadian Occupational Performance Measures (COPM)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Visual Analogue Scale/Score of leg
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Analogue Scale/Score of lumbar
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of recruited participants among those considered eligible
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Simulator Sickness Questionnaire (SSQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Self-report satisfaction questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Biochemical progression-free survival (BPFS) at 24 months
Endpoint domain: Mortality/survival
Primary endpoint: WHO Disability Assessment Scale (WHODAS 2.0)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Adherence to the Pain Care Plan
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Chalder Fatigue Questionnaire (CFQ)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Change in Short Form Health Survey (SF-36)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Visual Analog Scale (VAS) measuring Fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Post procedural Reflux Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Maximum oxygen consumption (Vo2max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety as determined by assessment of dose limiting toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Tolerability as determined by assessment of the maximum tolerated dose
Endpoint domain: Adverse events/effects
Primary endpoint: tumor size in injected lesions and non-injected lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Rate of pelvic recurrence at 3 years
Endpoint domain: Mortality/survival
Primary endpoint: Change in daily morning FeNO
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Time and duration of hemoglobin (Hb)≥9.0 g/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Behavioral reaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Tumor Diameter Size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Pathologic lymph node metastasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Extratumoral invasion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: AUCinf of balcinrenone/dapagliflozin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of balcinrenone/dapagliflozin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: t½λz of balcinrenone/dapagliflozin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Dose-Limiting Toxicities (DLT) of HX044
Endpoint domain: Adverse events/effects
Primary endpoint: Total Occurrence of ACM and CV clinical events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of subjects achieving at least a 4-point improvement in WI-NRS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Speech reception thresholds in noise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: safety and efficacy of the decision algorithm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Rate of successful surgical procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Satisfaction with conserved breast
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in temperature of skin surface in the neck area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Speech initiation latency in milliseconds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and tolerability of Trimer 4571 vaccine
Endpoint domain: Adverse events/effects
Primary endpoint: False-negative lung nodules
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Complete response (CR) + very good partial response (VGPR) at 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average Craving Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Age at loss of ambulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wong-Baker Faces Pain Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The Child Fear Scale (CFS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: The Children's Anxiety Meter (CAM)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sleep depth
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Area under the concentration-time curve (AUC0-Tau, ss) of EE and NEA without coadministration with VH4524184
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration-time curve (AUC0-Tau, ss) of EE and NEA with coadministration with VH4524184
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum plasma concentration (Cmax) for EE and NEA without coadministration with VH4524184
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax for EE and NEA with coadministration with VH4524184
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WCRF/AICR score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-exertional dyspnoea
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Blood concentration of phenolics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Fugl-Meyer Assessment (FMA) - upper extremity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nine-hole peg test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Action research arm test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional independence measurement
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Communication in Oncology
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Quality of Physician-Patient Interaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Entrustable Professional Activities Assessment
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Hypothalamic Amenorrhea (HA) duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in steatosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Patient Health Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rates of reported side effects
Endpoint domain: Adverse events/effects
Primary endpoint: Device efficacy in reducing lymphedema burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Enteroendocrine L cell (EEC) function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Lipid metabolism change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Macromolecular proton content (MPC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gut microbiota composition and variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Incidence and severity of grade ≥ 3 adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Percent of planned tagraxofusp dose received
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Subjective Rating of Dryness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective Rating of Clarity of Vision
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Calf muscle atrophy measured by calf circumference
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Calf muscle atrophy measured by hand held dynamometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Permanent pacemaker implantation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: surgical and post-operative complications
Endpoint domain: Adverse events/effects
Primary endpoint: surgical and post-operative function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in Modified Ashworth Scale score for elbow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Adherence to repeat colonoscopy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Postoperative hemovac or JP total drainage amount
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Device Deficiencies
Endpoint domain: Adverse events/effects
Primary endpoint: Trunk control measurement scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trunk Position Sense
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived Effectiveness - Persuasive Potential
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perceived Effectiveness - Perceived Behavioral Impact
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Risk Perceptions: Absolute/Relative Risks of Cigarette vs. E-cigarette Use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Behavioral Intentions to Use Tobacco
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change from baseline in mRSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of small bowel bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Concentration of TNF-ALPHA gene expression in joint tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Surgeon perspective on blue light illumination
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Surgeon perspective on ease of use
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Area under the plasma concentration versus time curve (AUC) of BDNF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evaluation of survival
Endpoint domain: Mortality/survival
Primary endpoint: Menstrual Physiological Infrequency Table (MDQ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Longitudinal change of heart rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Longitudinal change of arterial blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Longitudinal change of stroke volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Longitudinal change of myocardial strain imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Acceptability of Bedtime Routine
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Feasibility of Bedtime Routine
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Composite of stroke, death and intracerebral bleeding
Endpoint domain: Mortality/survival
Primary endpoint: SNR pre-resection recording
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recommended phase 2 dose (RP2D) of copanlisib in combination with degarelix
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of pCR or MRD at Radical Prostatectomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Incidence of ITP
Endpoint domain: Mortality/survival
Primary endpoint: Number of patients with adverse event (AE) reports
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in the Total Nasal Symptom Score (TNSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline for [18F]PBR06-PET scans for microglial activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Impact on clinical decision-making
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Consistency between EG-i30 and ABL90 analyzers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation between EG-i30 and ABL90 analyzers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bias at clinical decision levels between EG-i30 and ABL90 analyzers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of immediate adverse events (AEs) within 30 minutes after each/any injection
Endpoint domain: Adverse events/effects
Primary endpoint: Presence of solicited injection site reactions through 7 days after each/any injection
Endpoint domain: Adverse events/effects
Primary endpoint: Presence of medically attended adverse events (MAAEs) through 180 days after the last injection
Endpoint domain: Adverse events/effects
Primary endpoint: Survival at 90 days without any treatment complications
Endpoint domain: Mortality/survival
Primary endpoint: Accuracy rate of ChatGPT-4 in predicting ICU indications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of Inappropriate Referrals
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of pills used
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Urinary Flavonoid Biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interferon gamma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interleukins 1B, 6, 8, 10
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tumor necrosis factor alpha
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants with modified Mayo score (MMS) Clinical Remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: SLE Responder Index (SRI) - 4 response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnosis of opioid use disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes from Baseline miRNA-135A
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes from Baseline Rock2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes from Baseline Add1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of periodontal diseases
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients consuming Mediterranean diet
Endpoint domain: Life impact
Endpoint subdomain: Dietary habits
Primary endpoint: Area Under the Milk Concentration-time Curve from Time 0 to Infinity (AUC0-inf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Observed Milk Concentration of BRIUMVI™ (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time of Cmax (Tmax) of BRIUMVI™ in Milk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complication; wound problem
Endpoint domain: Adverse events/effects
Primary endpoint: Internalizing disorder symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: care stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percent of Weight Loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in CD8 PET SUVmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change from baseline in CAT total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients achieving a ≥ 2-point reduction in CAT total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the Drinker Inventory of Consequences (DrInC)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: pulmonary vascular remodeling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Hair color
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants experiencing a response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of complications related to the surgery
Endpoint domain: Adverse events/effects
Primary endpoint: annualized bleeding rates (ABR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: annualized joint bleeding rates (AJBR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: haemophilia-specific quality-of-life (Haemo-QoL-A) scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: hemophilia Joint Health Scores (HJHS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of events related to hypotension
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of events related to hyperkalemia
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of events related to renal impairment/renal failure
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of events related to dehydration
Endpoint domain: Adverse events/effects
Primary endpoint: Pathological Affective Dependence Scale (PADS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing